|
|
|
|
Molecular Pharmacology, Vol 12, 345-352, Copyright © 1976 by the American Society for Pharmacology and Experimental Therapeutics
1 Department of Pharmacology, Medical College of Virginia, Virginia Commonwealth University, Richmond,
Virginia 23298
The effect of
9-tetrahydrocannabinol (
9-THC) and 18 of its metabolites and analogues
on the high-affinity uptake of [3H]serotonin into a synaptosome-enriched homogenate of
rat forebrain has been determined in vitro. Each of the cannabinoids which inhibited
[3H]serotonin accumulation did so in a dose-responsive manner. Although some of these
compounds do not possess typical
9-THC or marijuana-like effects in laboratory animals or humans, each of the cannabinoids tested, with one exception, inhibited the
uptake of serotonin at the concentrations used. A positional activity requirement for the
phenolic hydroxyl group was demonstrated by the increased IC50 values for the abnormal analogues of
8-THC and cannabidiol relative to their parent compounds.
8-THC
and cannabinol were slightly more active than
9-THC, implying that the orientation of
protons at the C-8 position may be important for activity. Pseudoequatorial hydroxylation of C-8 resulted in diminished activity, while pseudoaxial hydroxylation of C-8
resulted in little change. In addition, equatorial hydroxylation of C-9 diminished activity relative to axial hydroxylation of C-9. It was also found that hydroxylation of C-9
increased the IC-50 almost 3-fold relative to the C-9 methylated compound. Finally, it was
determined that nonpolar substitution at C-11 diminished the activity only slightly
compared to the reduction obtained by hydroxylation of C-11.